Instead, a protocol is determined based on your goals and starting weight
What began with an obscure lizard and a difficult research question ended by opening one of the most important new chapters in metabolic treatment.
Poor sleep habits can diminish results
Phase 2 trial data (NCT04881760) reported diarrhoea in approximately 2030% of participants at higher doses, with symptoms most pronounced during dose-escalation phases
If those root causes remain unaddressed, cravings often return aggressively after stopping a GLP-1
When estrogen is too low or fluctuating (common during perimenopause/menopause), the body can store more fat, especially around the midsection, and insulin sensitivity can decline, which may slow weight loss progress even with GLP-1s